Showing results (1341-1350 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|July 27, 2026
Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practiceTom Boyles, Jayne Ellis, Nicholas Feasey, et al.
The Lancet. Infectious Diseases|August 4, 2026
Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance studyBuze Chala, Lucien Platon, Yssimini Nadège Guillène Tibiri, et al.
The Lancet. Infectious Diseases|August 21, 2026
Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort studyYin Mo, Xinxin Hao, Ying Ding, et al.
The Lancet. Infectious Diseases|August 14, 2026
Guiding principles for pragmatic randomised trials of tuberculosis treatmentsPatrick P J Phillips, Samuel G Schumacher, Cara Cassino, et al.
The Lancet. Infectious Diseases|August 19, 2026
Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled studyFrederic Sawe, Lucy Koech, Souhir Neffati, et al.
The Lancet. Infectious Diseases|October 13, 2026
Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategyFederico Martinón-Torres, Josefina L Razzini, Iago Giné-Vázquez, et al.
The Lancet. Infectious Diseases|October 13, 2026
Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworksAlejandro Díez-Vidal, Pilar Vizcarra, Carlos M Oñoro-López, et al.
The Lancet. Infectious Diseases|October 8, 2026
When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedsideCornelia Lass-Flörl, Roya Vahedi-Shahandashti
The Lancet. Infectious Diseases|September 7, 2026
Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping reviewKenneth Chan, Caitlin Greenland-Bews, Daniel P Carter, et al.
The Lancet. Infectious Diseases|August 31, 2026
Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trialLindsey R Baden, Nirav S Shah, Sean T H Liu, et al.
Pageof 271